Harvard Apparatus Regenerative Technology, Inc. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$219K↓-15.1%
2025-09-30$123K↑+108.5%$-2M↑+8.6%-1393.5%
2025-06-30$317K↑+466.1%$-2M↑+27.0%-578.2%
2025-03-31$45K↓-21.1%$-2M↑+18.3%-3711.1%
2024-12-31$258K↑+309.5%
2024-09-30$59K↑+47.5%$-2M↓-15.2%-3150.8%
2024-06-30$56K$-2M↑+4.4%-4430.4%
2024-03-31$57K$-2M↑+29.8%-3545.6%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$219K
↓-15.1% -$39K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 56 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+839.3pts
-110.7%
Operating Margin↑+1757.4pts
-1393.5%
Net Margin↑+1770.4pts
-1382.1%

Go deeper